Equities

China Meheco Group Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

China Meheco Group Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)10.55
  • Today's Change-0.11 / -1.03%
  • Shares traded12.25m
  • 1 Year change-3.03%
  • Beta-0.2165
Data delayed at least 15 minutes, as of Feb 13 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

China Meheco Group Co Ltd is a China-based company mainly engaged in pharmaceutical commercial business. The Company mainly operates three segments. The Pharmaceutical Industry segment is mainly engaged in the production and sales of drugs, including chemical preparations, chemical active pharmaceutical ingredients, traditional Chinese patent medicines and simple preparations, Chinese herbal pieces, and others. The Pharmaceutical Commercial segment is mainly engaged in product distribution business, including diagnostic drugs and reagents, medical consumables, medical devices, special medical products, medical beauty products, traditional Chinese patent medicines and simple preparations, Chinese medicinal materials and decoction pieces, biological agents, and others. The International Trade segment operates products including chemical raw materials and preparations, biological products, medical devices, diagnostic reagents, dressings and consumables, and others.

  • Revenue in CNY (TTM)33.94bn
  • Net income in CNY543.08m
  • Incorporated1997
  • Employees8.37k
  • Location
    China Meheco Group Co LtdNo. 18Guangming Middle StreetDongcheng DistrictBEIJING 100073ChinaCHN
  • Phone+86 1 067164267
  • Fax+86 1 067152359
  • Websitehttps://www.meheco.com
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
600056:SHH since
announced
Transaction
value
HQ Pharma Co LtdAnnounced31 Dec 202531 Dec 2025Announced2.43%75.04m
Beijing Jinsui Technology Development Co LtdAnnounced13 May 202513 May 2025Announced3.03%41.94m
Data delayed at least 15 minutes, as of Feb 13 2026.

Institutional shareholders

4.00%Per cent of shares held by top holders
HolderShares% Held
China Investment Corp. (Investment Management)as of 30 Sep 202430.51m2.04%
China Southern Asset Management Co., Ltd.as of 30 Jun 202511.23m0.75%
The Vanguard Group, Inc.as of 04 Feb 20264.26m0.29%
China Asset Management Co., Ltd.as of 30 Jun 20254.21m0.28%
Fullgoal Fund Management Co., Ltd.as of 30 Jun 20252.13m0.14%
GF Fund Management Co., Ltd.as of 30 Jun 20251.89m0.13%
Tian Hong Asset Management Co., Ltd.as of 30 Jun 20251.65m0.11%
Dimensional Fund Advisors LPas of 05 Feb 20261.62m0.11%
Harvest Fund Management Co., Ltd.as of 30 Jun 20251.14m0.08%
Shanghai Guotai Junan Securities Assets Management Co., Ltd.as of 30 Jun 20251.10m0.07%
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.